BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9064972)

  • 1. [Sympathetic nervous system in heart failure: effect of catecholamines and nitric oxide].
    Drexler H
    Z Kardiol; 1996; 85 Suppl 6():247-52. PubMed ID: 9064972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adrenergic beta receptors and guanine nucleotide binding proteins (G-proteins) of the failing human heart].
    Böhm M; Schwinger RH; Erdmann E
    Z Kardiol; 1992; 81 Suppl 4():23-31. PubMed ID: 1337808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.
    Bristow MR; Hershberger RE; Port JD; Gilbert EM; Sandoval A; Rasmussen R; Cates AE; Feldman AM
    Circulation; 1990 Aug; 82(2 Suppl):I12-25. PubMed ID: 2164894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-adrenergic component of the sympathetic nervous system in congestive heart failure.
    Leier CV; Binkley PF; Cody RJ
    Circulation; 1990 Aug; 82(2 Suppl):I68-76. PubMed ID: 2164897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the sympathetic nervous system in heart failure].
    Dietz R; Osterziel KJ
    Z Kardiol; 1991; 80 Suppl 8():31-6. PubMed ID: 1665628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral factors in chronic heart failure. A review.
    Kölbel F
    Cor Vasa; 1992; 34(1):67-70. PubMed ID: 1337731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic receptor--effector coupling during post-natal development.
    Robinson RB
    Cardiovasc Res; 1996 Feb; 31 Spec No():E68-76. PubMed ID: 8681348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sympathetic nervous system and endothelial function in heart failure].
    Binggeli C; Wenzel RR; Noll G
    Praxis (Bern 1994); 1996 Feb; 85(8):234-44. PubMed ID: 8701190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
    Bendall JK; Damy T; Ratajczak P; Loyer X; Monceau V; Marty I; Milliez P; Robidel E; Marotte F; Samuel JL; Heymes C
    Circulation; 2004 Oct; 110(16):2368-75. PubMed ID: 15466641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and role of the presynaptic and myocardial Na+/H+ exchanger NHE1: effects on the sympathetic nervous system in heart failure.
    Leineweber K; Heusch G; Schulz R
    Cardiovasc Drug Rev; 2007; 25(2):123-31. PubMed ID: 17614935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.
    Elenkov IJ; Wilder RL; Chrousos GP; Vizi ES
    Pharmacol Rev; 2000 Dec; 52(4):595-638. PubMed ID: 11121511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model.
    Nap A; Belterman CN; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):220-7. PubMed ID: 14689369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction.
    Tsutsumi T; Ide T; Yamato M; Kudou W; Andou M; Hirooka Y; Utsumi H; Tsutsui H; Sunagawa K
    Cardiovasc Res; 2008 Mar; 77(4):713-21. PubMed ID: 18065771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ouabain treatment is associated with upregulation of phosphatase inhibitor-1 and Na+/Ca(2+)-exchanger and beta-adrenergic sensitization in rat hearts.
    El-Armouche A; Jaeckel E; Boheler KR; Boknik P; Hertle B; Neumann J; Eschenhagen T
    Biochem Biophys Res Commun; 2004 May; 318(1):219-26. PubMed ID: 15110776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
    Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
    J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.